List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm

    SBC: Plant Vax, Inc.            Topic: 106

    DESCRIPTION provided by applicant Organophosphorus OPs compound are potent neurotoxic chemicals that are widely used in medicine industry and agriculture most notably as insecticides The neurotoxicity which is primarily a result of AChE inhibition may take the form of cholinergic crisis and death as a consequence of acute exposure or psychiatric symptoms and may lead to delayed neuropath ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  2. Plasmodium Falciparum Whole Sporozoite Malaria Vaccine

    SBC: SANARIA INC.            Topic: NIAID

    DESCRIPTION provided by applicant The ideal tool for eliminating Plasmodium falciparum Pf the causative agent of of all malaria deaths would be a highly effective vaccine that prevents blood stage infection and thereby prevents the disease and transmission The only immunogens demonstrated able to induce andgt sustained months protective efficacy in humans are Pf sporozoit ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  3. TB Diagnostics at the Point of Care

    SBC: AKONNI BIOSYSTEMS INC.            Topic: NIBIB

    DESCRIPTION provided by applicant Of all diseases tuberculosis TB represents one of if not the greatest health disparity between whites and minorities For every TB infected white person in the United States there are an estimated African Americans Latinos Native Americans Asians and Native Hawaiian Pacific Islanders with this disease Compounded with this dispari ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Augmented Reality Head Mounted Display for Magnetic Resonance Imaging Guided Inte

    SBC: Robin Medical, Inc.            Topic: 102

    DESCRIPTION provided by applicant The broad long term objective is to develop a low cost easy to use system that can convert diagnostic MRI scanner into a functional neurosurgical MRI suite The specific aims of the project are Develop the display only mode of the HMD that integrates MRI realtime scans and device tracking annotation into a stereoscopic D display Feasibility of such HMD ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Low-Dose MRI-Compatible Molecular Breast Imaging Device

    SBC: Weinberg Medical Physics, Inc.            Topic: 102

    DESCRIPTION provided by applicant Contrast enhanced MRI has been proven to be a very sensitive modality for the early diagnosis of breast cancer in young women and or in women with radiographically dense breasts The American Cancer Society recommends that high risk women with lifetime risk greater than should receive annual breast MRI screening Depending on the practitioner and study char ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  6. DNA Repair-on-a-Chip: Spatially Encoded Microwell Arrays

    SBC: TREVIGEN, INC.            Topic: NIEHS

    DESCRIPTION provided by applicant Preserving genomic integrity is essential in order to suppress cancer neurodegeneration aging and other diseases At odds with genomic preservation is DNA damage which can drive mutations sequence rearrangements and cellular toxicity DNA damage is unavoidable as DNA damaging agents are present in our environment and in our cells To counteract the deleter ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Optimization of a DNA Subunit Regimen for an HIV Vaccine

    SBC: PROFECTUS BIOSCIENCES, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Our primary approach to develop an effective prophylactic vaccine against HIV utilizes a novel immunogen called the Full Length Single Chain FLSC that consists of gp derived from HIV BaL genetically linked via a amino acid linker to the D D domains of human CD Rhesus macaques were inoculated with rhFLSC a surrogate version of FLSC that contains CD derived from rhe ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Long-Acting G-CSF Analog for Treating ARS

    SBC: Bolder Biotechnology, Inc.            Topic: NIAID

    DESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  9. An Intuitive Prosthetic System for Upper Extremity Amputees

    SBC: Infinite Biomedical Technologies, LLC            Topic: 102

    DESCRIPTION provided by applicant There are well over people living with upper limb loss in the United States today and in new amputations are of the upper limb The loss of an upper limb is devastating to a personandapos s quality of life their work productivity and it bring about many psychosocial challenges While there have been exciting technological advances which promise th ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Plasmodium Falciparum Whole Sporozoite Malaria Vaccine

    SBC: SANARIA INC.            Topic: NIAID

    DESCRIPTION provided by applicant The ideal tool for eliminating Plasmodium falciparum Pf the causative agent of of all malaria deaths would be a highly effective vaccine that prevents blood stage infection and thereby prevents the disease and transmission The only immunogens demonstrated in humans to be able to induce andgt protective efficacy that is sustained months are ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government